Drug Shortage Report for IMITREX
| Report ID | 213449 |
| Drug Identification Number | 02212188 |
| Brand name | IMITREX |
| Common or Proper name | Sumatriptan succinate injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 6MG |
| Dosage form(s) | SOLUTION LIQUID |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2x0.5mL (Refill pack / L’emballage de recharge) |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-11 |
| Estimated end date | 2024-01-12 |
| Actual end date | 2024-01-04 |
| Shortage status | Resolved |
| Updated date | 2024-01-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-01-05 | French | Compare |
| v3 | 2024-01-05 | English | Compare |
| v2 | 2023-12-15 | French | Compare |
| v1 | 2023-12-15 | English | Compare |
Showing 1 to 4 of 4